Profile
CADL VRTX REGN ALNY SGEN ARGX
Company Name Candel Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $280.27M $100.25B $60.38B $59.29B $43.15B $40.18B
Employees 0.04K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Paul-Peter Tak FOCIS, Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
CADL VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 3 4 1 3 4
Quant Rating Sell Neutral Buy Strong Sell Neutral Buy
Trading
CADL VRTX REGN ALNY SGEN ARGX
Last Close $5.105 $396.62 $563.8 $447.43 $228.74 $722.01
High 52 $12.21 $516.74 $1179.37 $467.71 $228.74 $722.01
Low 52 $3.8 $366.54 $482.92 $224.58 $228.74 $519.76
Price vs. 52 Week High -58.19 % -23.25 % -52.19 % -4.34 % 0 % 0 %
Price vs. 52 Week Low 34.34 % 8.21 % 16.75 % 99.23 % 0 % 38.91 %
Total Return
CADL VRTX REGN ALNY SGEN ARGX
1 Month Return -19.1 % -16.02 % -1.35 % 6.64 % 0 % 4.59 %
3 Month Return -9 % -11.04 % 16.27 % 46.55 % 0 % 25.89 %
6 Month Return -35.17 % -18.43 % -16.53 % 84.18 % 0 % 16.22 %
9 Month Return 15.24 % -14.52 % -25.25 % 75.66 % 0 % 15.53 %
YTD Return -41.19 % -1.51 % -20.85 % 90.14 % 0 % 17.4 %
1 Year Return -16.04 % -17.12 % -52.19 % 76.75 % 0 % 36.89 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CADL VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.46 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -807.95 % 11.09 % 4.37 % -0.43 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 2.64 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
CADL VRTX REGN ALNY SGEN ARGX
Asset Growth 159.38 % -0.87 %
Gross Profit Growth 95.87 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year -100 % 45.6 %
Revenue 5 Year -100 % 163.93 %
Revenue 10 Year -100 % 1632.15 %
EBIT Growth -38.28 % -93.69 %
Net Income Growth -45.44 % -114.8 %
Net Income 3 Yeari Growth Per Share -38.15 % -122.89 %
Net Income 5 Yeari Growth Per Share -306.79 % -145.38 %
Net Income 10 Yeari Growth Per Share -306.79 % 33.84 %
Operating Income Growth 13.08 % -106.08 %
Operating Cash Flow Growth (CFG) 21.09 % -113.93 %
Operating 3 Year CFG -10.16 % -118.65 %
Operating 5 Year CFG -208.4 % -131.3 %
Operating 10 Year CFG -208.4 % 12.43 %
EPS Growth -32.82 % -114.8 %
EPS Diluted Growth -32.82 % -114.97 %
Book Value Per Share 375.4 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -6.33 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 587.53 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 587.53 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -40.82 % 116.42 %
Free Cash Flow Growth 22.08 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
CADL VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM -97.7 % 86.11 % 81.98 % 83.64 % 79.1 % 65.32 %
Return on Assets TTM -20.89 % 15.13 % 11.67 % -6.99 % -16.61 % 15.06 %
Return on Equity TTM -41 % 22.14 % 15.11 % -274.21 % -20.8 % 18.96 %
Return on Capital Employed TTM -39.68 % 19.72 % 11.45 % -5.52 % -21.46 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 91.46 % 84.06 % 101.33 % 237.3 %
EBT Per Ebit TTM 61.14 % 111.48 % 123.23 % 210.66 % 98.26 % 147.38 %
EBIT Per Revenue TTM -3620.5 % 34.36 % 27.83 % -7.32 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM -358.4 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Receivables Turnover TTM - 6.03 2.53 4.34 3.91 1.91
Payables Turnover TTM 0.5 0.43 3.54 3.93 1.97 0.88
Inventory Turnover TTM - 1.06 0.8 5.62 0.96 2.21
Fixed Asset Turnover TTM 48.8 % 431.08 % 293.64 % 355.68 % 665.41 % 5009.77 %
Asset Turnover TTM 0.94 % 47.51 % 37.19 % 53.92 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM -0.58 14.98 45.13 -0.12 -2.46 -1.07
Free Cash Flow Per Share TTM -0.58 13.63 36.58 -0.4 -2.88 -1.09
Cash Per Share TTM 195.55 % 3036 % 7107.14 % 2203.63 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -2989.4 % 33.68 % 33.37 % -0.63 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.12 % 90.99 % 81.05 % 335.21 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -358.4 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM -9.36 28.65 15.7 -1138.28 -81.26 -520.99
Price To Operating Cash Flows Ratio TTM -8.79 26.1 12.84 -3774.78 -93.1 -617.61
Price Cash Flow Ratio TTM -8.79 26.1 12.84 -3774.78 -93.1 -617.61
Income Statement (TTM)
CADL VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0B $9.49B $11.75B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 82.74% 85.62% 79.1% 89.62%
EBITDA $-0.05B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -1.74 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
CADL VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $2.7B $1.25B $0.04B $0.03B
Total Liabilities $0.04B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.07B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.01B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.11B $22.53B $37.76B $4.24B $3.67B $6.2B
Cash Flow Statement (TTM)
CADL VRTX REGN ALNY SGEN ARGX
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.1216
AARD Aardvark Therapeutics, Inc. Common Stock 8.375
ABCL AbCellera Biologics Inc. 3.985
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.825
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.365
ABPWW 0.0311
ABSI Absci Corporation 2.335
ABUS Arbutus Biopharma Corporation 3.925
ABVC ABVC BioPharma, Inc. 2.645
ABVX Abivax SA American Depositary Shares 85.2
ACAD ACADIA Pharmaceuticals Inc. 25.61
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7273
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.805
ACIU AC Immune SA 2.145
ETFs With Exposure to CADL
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00835 235.35
VTI Vanguard Total Stock Market Index Fund 0.00036 319.2
IBB iShares Biotechnology ETF 0 139.66
IWN iShares Russell 2000 Value ETF 0.00154 174.11
IWO iShares Russell 2000 Growth ETF 0.01484 307.795
BIB ProShares Ultra Nasdaq Biotechnology 0 56.57
VXF Vanguard Extended Market Index Fund 0.00312 205.82
HDG ProShares Hedge Replication ETF 0.000996246 50.6157
UWM ProShares Ultra Russell2000 0.00547265 44.08
VTHR Vanguard Russell 3000 Index Fund 0.00022 286.205
IWC iShares Micro-Cap ETF 0.05778 141.47
URTY ProShares UltraPro Russell2000 0.00434485 49.13
VTWV Vanguard Russell 2000 Value Index Fund 0.00182 153.475
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0.01 74.33
SBIO ALPS Medical Breakthroughs ETF 0.14 35.745
VFMO Vanguard U.S. Momentum Factor ETF 0.01703 180.645
VTWG Vanguard Russell 2000 Growth Index Fund 0.01694 224.915
VTWO Vanguard Russell 2000 Index Fund 0.00957 95.18
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 44.86
VMO.TO Vanguard Global Momentum Factor ETF 0.06622 73.36
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00031 107.94
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 107.93
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00019 51.37
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00019 51.37
VBINX Vanguard Balanced Index Fund Investor Shares 0 51.36
IBBQ Invesco Nasdaq Biotechnology ETF 0.01 23.685
VTSAX Vanguard Total Stock Market Index Fund 0 154.49
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 6.895
R2US.L SPDR Russell 2000 US Small Cap UCITS ETF 0.009256 68.49
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00312 155.01
VITSX Vanguard Total Stock Market Index Fund 0 154.52
XRS2.F Xtrackers Russell 2000 UCITS ETF 0.00769026 318.35
SC0K.DE Invesco Russell 2000 UCITS ETF 0.0085 103.06
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00312 155.02
RTYS.L Invesco Russell 2000 UCITS ETF 0.0085 119.95
XRSG.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00769026 25893.5
XRSU.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00769026 347.85
ZPRR.DE SPDR Russell 2000 US Small Cap UCITS ETF 0.009256 58.78
R2SC.L SPDR Russell 2000 US Small Cap UCITS ETF 0.009256 50.99
XRS2.DE Xtrackers Russell 2000 UCITS ETF 0.00769026 298.75
VTS.AX Vanguard US Total Market Shares Index ETF 0.00036 487.42
VEMPX Vanguard Extended Market Index InstlPlus 0.00312 382.55
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00036 289.86
RSSL Global X Funds 0.01 92.41
RFLR Innovator ETFs Trust 0.01 27.08
Unlock